A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with very limited therapeutic options. Fibroblast growth factor (FGF) signals play important roles in mesothelioma cell growth. Several FGFs and FGF receptors (FGFRs) are predicted targets of the miR‐15/16 family, which is downregulate...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12150 |
id |
doaj-b094d40bad314cdfb3c62ed871bcdebd |
---|---|
record_format |
Article |
spelling |
doaj-b094d40bad314cdfb3c62ed871bcdebd2020-11-25T01:59:32ZengWileyMolecular Oncology1574-78911878-02612018-01-01121587310.1002/1878-0261.12150A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesotheliomaKarin Schelch0Michaela B. Kirschner1Marissa Williams2Yuen Y. Cheng3Nico vanZandwijk4Michael Grusch5Glen Reid6Asbestos Diseases Research Institute Sydney AustraliaAsbestos Diseases Research Institute Sydney AustraliaAsbestos Diseases Research Institute Sydney AustraliaAsbestos Diseases Research Institute Sydney AustraliaAsbestos Diseases Research Institute Sydney AustraliaDepartment of Medicine I Institute of Cancer Research Medical University of Vienna AustriaAsbestos Diseases Research Institute Sydney AustraliaMalignant pleural mesothelioma (MPM) is an aggressive malignancy with very limited therapeutic options. Fibroblast growth factor (FGF) signals play important roles in mesothelioma cell growth. Several FGFs and FGF receptors (FGFRs) are predicted targets of the miR‐15/16 family, which is downregulated in MPM. The aim of this study was to explore the link between the miR‐15/16 family and the FGF axis in MPM. Expression analyses via RT‐qPCR showed downregulation of the FGF axis after transfection with miR‐15/16 mimics. Direct interaction was confirmed by luciferase reporter assays. Restoration of miR‐15/16 led to dose‐dependent growth inhibition in MPM cell lines, which significantly correlated with their sensitivity to FGFR inhibition. Treatment with recombinant FGF2 prevented growth inhibition and further reduced the levels of FGF/R‐targeting microRNAs, indicating a vicious cycle between miR‐15/16 down‐ and FGF/FGFR signaling upregulation. Combined inhibition of two independent miR‐15/16 targets, the FGF axis and Bcl‐2, resulted in additive or synergistic activity. Our data indicate that post‐transcriptional repression of FGF‐mediated signals contributes to the tumor suppressor function of the microRNA‐15/16 family. Inhibiting hyperactivated FGF signals and Bcl‐2 might serve as a novel therapeutic combination strategy in MPM.https://doi.org/10.1002/1878-0261.12150fibroblast growth factor, fibroblast growth factor receptormalignant pleural mesotheliomamicroRNA‐15microRNA‐16 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Karin Schelch Michaela B. Kirschner Marissa Williams Yuen Y. Cheng Nico vanZandwijk Michael Grusch Glen Reid |
spellingShingle |
Karin Schelch Michaela B. Kirschner Marissa Williams Yuen Y. Cheng Nico vanZandwijk Michael Grusch Glen Reid A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma Molecular Oncology fibroblast growth factor, fibroblast growth factor receptor malignant pleural mesothelioma microRNA‐15 microRNA‐16 |
author_facet |
Karin Schelch Michaela B. Kirschner Marissa Williams Yuen Y. Cheng Nico vanZandwijk Michael Grusch Glen Reid |
author_sort |
Karin Schelch |
title |
A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma |
title_short |
A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma |
title_full |
A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma |
title_fullStr |
A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma |
title_full_unstemmed |
A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma |
title_sort |
link between the fibroblast growth factor axis and the mir‐16 family reveals potential new treatment combinations in mesothelioma |
publisher |
Wiley |
series |
Molecular Oncology |
issn |
1574-7891 1878-0261 |
publishDate |
2018-01-01 |
description |
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with very limited therapeutic options. Fibroblast growth factor (FGF) signals play important roles in mesothelioma cell growth. Several FGFs and FGF receptors (FGFRs) are predicted targets of the miR‐15/16 family, which is downregulated in MPM. The aim of this study was to explore the link between the miR‐15/16 family and the FGF axis in MPM. Expression analyses via RT‐qPCR showed downregulation of the FGF axis after transfection with miR‐15/16 mimics. Direct interaction was confirmed by luciferase reporter assays. Restoration of miR‐15/16 led to dose‐dependent growth inhibition in MPM cell lines, which significantly correlated with their sensitivity to FGFR inhibition. Treatment with recombinant FGF2 prevented growth inhibition and further reduced the levels of FGF/R‐targeting microRNAs, indicating a vicious cycle between miR‐15/16 down‐ and FGF/FGFR signaling upregulation. Combined inhibition of two independent miR‐15/16 targets, the FGF axis and Bcl‐2, resulted in additive or synergistic activity. Our data indicate that post‐transcriptional repression of FGF‐mediated signals contributes to the tumor suppressor function of the microRNA‐15/16 family. Inhibiting hyperactivated FGF signals and Bcl‐2 might serve as a novel therapeutic combination strategy in MPM. |
topic |
fibroblast growth factor, fibroblast growth factor receptor malignant pleural mesothelioma microRNA‐15 microRNA‐16 |
url |
https://doi.org/10.1002/1878-0261.12150 |
work_keys_str_mv |
AT karinschelch alinkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT michaelabkirschner alinkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT marissawilliams alinkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT yuenycheng alinkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT nicovanzandwijk alinkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT michaelgrusch alinkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT glenreid alinkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT karinschelch linkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT michaelabkirschner linkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT marissawilliams linkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT yuenycheng linkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT nicovanzandwijk linkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT michaelgrusch linkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma AT glenreid linkbetweenthefibroblastgrowthfactoraxisandthemir16familyrevealspotentialnewtreatmentcombinationsinmesothelioma |
_version_ |
1724964223163826176 |